ArticlePeerJ2025
Unveiling the immune and vitamin profiles of blood: the potential biomarkers for alopecia areata.
Article in PeerJ, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Alopecia areata is a hair follicle disorder characterized by the development of multiple circular bald patches on the scalp, often accompanied by elevated cytokine production and immune cell infiltration around hair follicles. Our aspiration is to explore whether blood analysis can reveal additional factors that contribute to the disparities between individuals with alopecia areata and those who are healthy. Such research could potentially establish a robust foundation for the advancement of future therapeutic strategies. Methods: In Fujian, China, we have collected blood samples from a cohort of 28 alopecia areata patients and a control group of 28 healthy individuals for comparative analysis. A detailed assessment of cytokines, eosinophil counts, vitamin levels, and immunoglobulin profiles within these samples was conducted. Subsequently, statistical analysis was applied to elucidate the differences between the two groups. Results: While the blood analysis revealed higher average levels of IL-4, IL-10, and TNF-α in alopecia areata patients compared to healthy individuals, these differences were not statistically significant. Similarly, vitamin levels showed no significant variation between the patient and healthy groups. However, the Wilcoxon rank sum test identified a significant increase in IFN-γ and a significant decrease in immunoglobulin IgG4 levels among alopecia areata patients, pointing to a possible role in the disease's pathogenesis. Receiver operating characteristic (ROC) curve analysis had demonstrated that the area under the ROC curve (AUC) for IFN-γ and IgG4 was 0.656 and 0.704, respectively, suggesting that IFN-γ and IgG4 had a certain discrimination effect on alopecia areata. Utilizing the Youden index to optimize specificity, we propose that IgG4 levels below 824.85 mg/L and IFN-γ levels above 0.565 pg/mL could serve as biomarkers for assessing the risk of alopecia areata. Conclusions: These findings highlight the need for further exploration of the link among alopecia areata, IgG4- and IFN-γ-related mechanisms, potentially uncovering novel therapeutic targets for managing this condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.